When we analyzed Bajorin’s criteria according to FGFR status, they were fulfilled in FGFR WT patients ( p = 0.00058) but did not reach statistical significance in FGFR GA patients ( p = 0.11) ( Figure 1 E).
← all excerpts
Prognostic Value and Clinical Significance of FGFR Genomic Alterations (GAs) in Metastatic Urothelial Cancer Patients.
2
0.1100
0.1100
The sentences
FGFR GA patients showed a trend toward a better response to cisplatin and checkpoint inhibitors with regards to the WT cohort.